BIO unveils intellectual property rights report.June 18, 2012 -
At 2012 BIO International Convention, BIO will unveil findings from report titled "Taking Stock: the Gains of Global Biotechnology Research from IPRs." Report will bring together experts to discuss how IPRs have affected innovation and development of new biotechnologies in develping countries and whether they contribute to growth in partnerships and other models of collaboration between biotechnology R/D actors such as universities, SMEs, and pharmaceutical manufacturers.
BIO to Release Intellectual Property Rights Report at 2012 BIO International Convention
Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
Press release date: June 14, 2012
WASHINGTON -- The Biotechnology Industry Organization (BIO) will unveil findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston, Mass.
"Taking Stock: the Gains of Global Biotechnology Research from IPRs"
The report, titled "Taking Stock: the Gains of Global Biotechnology Research from IPRs," will bring together experts to discuss how IPRs have affected innovation and the development of new biotechnologies and whether they contribute to growth in partnerships and other models of collaboration between biotechnology R&D actors such as universities, small and medium sized entities (SMEs) and pharmaceutical manufacturers.
WHO: Meir Pugatch, Managing Director and Founder, Pugatch Consilium
David Torstensson, Senior Consultant, Pugatch Consilium
Rachel Chu, Senior Consultant, Pugatch Consilium
Jennifer Dent, VP, Commercialization and Alliance Management, BIO Ventures for Global Health
Zakhar Golant, Vice Chairman, Committee of the Economic Development, Industrial Policy and Trade, Government of St. Petersburg
Amir Naiberg, CEO, Yeda R&D Co Ltd
Nadezhda Orlova, Partner, Research Company Abercade
WHAT: The session will unveil a new report, titled "Taking Stock: the Gains of Global Biotechnology Research from IPRs," which focuses on the extent to which intellectual property rights play a role in encouraging upstream R&D and downstream commercialization in biotechnology in developed and developing countries.
WHERE: BIO International Convention, Boston Convention & Exhibition Center, Room 259A
WHEN: Tuesday, June 19, 2:00 pm - 3:30 pm
WHY: This report will highlight the need for intellectual property rights and the importance for developing countries to advance in the biotechnology field. In order for countries to build a strong and thriving biotech sector, strong intellectual property protection is a must.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW.
For more information:
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech